Workflow
Alphabet Q2: Don't Miss Out On This Growth Powerhouse
Seeking Alpha· 2025-08-21 23:11
Hi, my name is Kody. Aside from my articles here on Seeking Alpha, I am also a regular contributor to Sure Dividend, The Dividend Kings, and iREIT+Hoya Capital. I have been investing since September 2017 (age 20) and interested in dividend investing since about 2009.Since July 2018, I have ran Kody's Dividends. This is a blog that is documenting my journey towards financial independence using dividend growth investing as the means to transform the dream of financial independence into a reality. It's also th ...
ASTS vs. QCOM: Which Connectivity Stock Has Better Growth Potential?
ZACKS· 2025-08-21 23:11
Key Takeaways AST SpaceMobile, Inc. (ASTS) and Qualcomm Incorporated (QCOM) are pivotal players in the evolution of global mobile connectivity. AST SpaceMobile is building the world's first and only global cellular broadband network in space, accessible directly by standard smartphones (4G-LTE/5G devices) for commercial and government use, leveraging its extensive Intellectual Property and patent portfolio. The SpaceMobile Service is provided by a constellation of high-powered, large phased-array satellites ...
Crown Royal Chocolate Flavored Whisky Debuts Nationwide With Endless Pairing Possibilities
Prnewswire· 2025-08-21 23:11
Award-winning whisky Crown Royal introduces a silky smooth blend infused with rich chocolate flavor, crafted for surprising pairings in any cocktail. NEW YORK, Aug. 21, 2025 /PRNewswire/ -- Building its celebrated portfolio, Crown Royal is unveiling its latest flavor, Crown Royal Chocolate Flavored Whisky. This limited-edition blend combines carefully selected Crown Royal whiskies with rich chocolate flavor for a velvety finish that pairs in ways you might not expect. Crown Royal Chocolate Martini featuring ...
Walmart Q2 FY26: Growth Is Intact, But Profit Pressure Weighed On Shares
Seeking Alpha· 2025-08-21 23:10
Walmart Inc.'s (NYSE: WMT ) latest quarter shows why it remains such a good barometer of the U.S. consumer. Sales were strong, at $177.4 billion, up nearly 5% even after a $1.5 billion hit from weaker currencies. The company I'm passionate about finance and investing, focusing on business analysis, fundamental analysis, valuation, and long-term growth, especially in sectors like AI, fintech, finance and tech. I study finance and economy and have hands-on experience in equity research, financial modeling, an ...
Coty shares slump on surprise second quarter loss
Proactiveinvestors NA· 2025-08-21 23:08
About the publisher About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examine ...
INVESTOR REMINDER: Berger Montague Notifies Altimmune, Inc. (NASDAQ: ALT) Investors of a Class Action Lawsuit and Deadline
Prnewswire· 2025-08-21 23:06
诉讼公告 - 律师事务所Berger Montague PC宣布对Altimmune Inc提起集体诉讼,代表在2023年8月10日至2025年6月25日期间购买或获得该公司公开交易证券的投资者 [1] - 投资者需在2025年10月6日前申请成为首席原告代表 [2] 公司背景 - Altimmune总部位于马里兰州盖瑟斯堡,是一家临床阶段生物制药公司,专注于开发治疗肥胖和肝脏疾病的疗法,包括代谢功能障碍相关脂肪性肝炎(MASH) [2] 诉讼原因 - 2025年6月26日,Altimmune发布IMPACT Phase 2b试验的顶线结果,显示其药物Pemvidutide在纤维化减少主要终点上未能达到统计学显著性,原因是安慰剂反应高于预期 [3] - 尽管观察到积极趋势,但这一关键指标未达预期 [3] 市场反应 - 公告发布后,Altimmune股价单日暴跌53.2%,从2025年6月25日的7.71美元跌至6月26日的3.61美元 [4] 律师事务所信息 - Berger Montague成立于1970年,在证券集体诉讼领域具有先驱地位,在美国各地法院担任首席律师 [5] - 该律所在费城、明尼阿波利斯、特拉华、华盛顿特区、圣地亚哥、旧金山、芝加哥、宾夕法尼亚州马尔文和多伦多设有办事处 [5]
IGLB: Long Duration And Tight Spreads Will Result In Tears
Seeking Alpha· 2025-08-21 23:05
With an investment banking cash and derivatives trading background, Binary Tree Analytics ('BTA') aims to provide transparency and analytics in respect to capital markets instruments and trades. BTA focuses on CEFs, ETFs and Special Situations, and aims to deliver high annualized returns with a low volatility profile. We have been investing for over 20 years after obtaining a Finance major at a top university. It is not a matter of 'if', but a matter of 'when'. As we have said before timing in markets is al ...
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics
Prnewswire· 2025-08-21 23:05
公司监管合规问题 - Unicycive Therapeutics被指控违反联邦证券法 其关于满足FDA生产合规要求的声明存在虚假或误导性内容[2] - 公司被指控夸大其OLC新药申请(NDA)的监管前景 导致公开声明在关键时间点存在重大虚假和误导[2] FDA监管审查与公司披露 - 2025年6月10日公司披露FDA在其第三方制造供应商处发现cGMP合规缺陷 该供应商为合同开发和制造组织(CDMO)的分包商[3] - 由于发现的缺陷 FDA禁止与公司进行任何标签讨论[3] - 2025年6月30日FDA针对OLC新药申请发出完整回复函 再次引用先前发现的cGMP合规问题[4] 股价市场反应 - 2025年6月10日披露后公司股价下跌3.68美元 单日跌幅达40.89% 收盘报5.32美元[3] - 2025年6月30日完整回复函公告后股价进一步下跌2.03美元 跌幅29.85% 收盘报4.77美元[4] 法律程序进展 - 法院将任命主要原告 该原告需在类别中拥有最大财务利益且能代表类别成员监督诉讼[5] - 类别成员可选择通过律师申请成为主要原告 或保持缺席类别成员身份 该选择不影响最终赔偿分配[5]
Why BitMine's Massive Discount Could Signal a Major Opportunity
MarketBeat· 2025-08-21 23:04
公司战略转型 - 公司从比特币矿工转型为数字资产领域全球领导者 实施名为"5%炼金术"的新企业战略 目标收购5%的以太坊流通供应量 [2] - 转型执行速度惊人 自2025年6月下旬开始以太坊国库策略 以太坊持有量从7月28日的625,000枚快速增长至8月中旬的1,523,373枚 [3][5] - 公司已成为全球最大的企业以太坊持有者 恰逢机构对以太坊网络兴趣上升时期 [3] 资产与估值分析 - 公司数字资产和现金国库总价值超过66亿美元 其中包含1,523,373枚以太坊和192枚比特币 以及8000万美元现金 [1][4][14] - 股票市值仅约2.15亿美元 与66亿美元资产价值存在巨大差距 [2] - 基于7月底公布的1.217亿完全稀释股数计算 公司每股资产内在价值显著高于近期约50美元的股价 [6] 市场表现与流动性 - 平均日交易量飙升至64亿美元 成为美国流动性前十的股票 为机构投资者提供高流动性通道 [7] - 股价波动性较高 价格变动通常与以太坊每日价格波动相关 [8] 股东价值创造措施 - 董事会于2025年7月29日批准10亿美元股票回购计划 通过公开市场回购股票 [9][10] - 回购计划传递管理层认为股票被低估的信号 通过减少流通股数直接增加剩余股东的所有权权益和每股资产净值 [10][11] 机构投资者支持 - 获得知名科技和数字资产领域投资者的支持 包括ARK的Cathie Wood 传奇投资者Bill Miller III Founders Fund Pantera和Galaxy Digital [12] - 这些成熟投资者的参与为公司以太坊聚焦战略提供了重要可信度 表明他们看好该长期机会 [13] 投资价值主张 - 公司为投资者提供独特的公开交易渠道 可以折价获得大量且不断增长的以太坊国库资产暴露 [15] - 核心投资论点取决于市场最终缩小股票交易价格与其大量资产内在价值之间的差距 [16] - 公司拥有聚焦的战略 强大的机构支持和管理层积极部署工具创造股东价值 [17]
Walmart Stock Stumbles on Rare Earnings Letdown
Schaeffers Investment Research· 2025-08-21 23:03
财务表现 - 公司季度每股收益68美分 低于市场预期 为2022年以来首次未达预期[1] - 季度收入1774亿美元 超出市场预期[1] - 公司上调全年销售和利润指引[1] 股价表现 - 股价下跌4.3%至98.15美元 中断三日连涨走势[2] - 股价再次跌破100美元关键阻力位[2] - 年初至今股价仍保持8.6%涨幅[2] 运营挑战 - 面临关税压力及价格担忧[1] - 受到一次性费用影响[1] - 美国本土及电商销售表现强劲[1] 市场情绪 - 37家覆盖公司分析师中36家给予"买入"或更高评级[3] - 50日看涨/看跌期权成交量比率为1.98 高于过去87%的读数[3] - 当日看跌期权交易活跃 成交量114,000份 为日内平均水平的8倍[4] 期权交易 - 看跌期权成交量100,000份[4] - 最活跃合约为8月97美元、98美元和92美元看跌期权[4] - 所有执行价均有新开仓位[4]